Brief: Kyowa Kirin Co Says Tenapanor For Hyperphosphatemia Approved In Japan
25/09/2023 09:20
Sept 25 (Reuters) - Kyowa Kirin Co Ltd 4151.T :
* TENAPANOR FOR HYPERPHOSPHATEMIA APPROVED IN JAPAN
Source text for Eikon: ID:nGNXnnBDN
Further company coverage: 4151.T
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kyowa Kirin
See all newsFactbox: Global pharma companies that have publicly announced Trump drug pricing agreements
Factbox: Global pharma companies that have publicly announced Trump drug pricing agreements
Brief: Kyowa Kirin Announces Agreement With US Administration To Reduce Treatment Costs For Americans
Table: Kyowa Kirin 6-MTH group results (IFRS)
Brief: Kyowa Kirin Says European Commission Approves Crysvita For Infants With X-Linked Hypophosphataemia